Clinical Trials Directory

Trials / Completed

CompletedNCT01954758

The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer

Clinical Study, International, Multicentre, Prospective, Randomised, Interventional and Controlled, Comparing Fresh Embryo Transfer (ET) Versus Frozen Embryo Transfer (FET) and Personalised Embryo Transfer (pET) Guided by the ERA (Endometrial Receptivity Analysis) Test as a Diagnostic Tool in Patients Treated by IVF/ICSI (in Vitro Fertilisation; Intra-cytoplasmic Sperm Injection)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
569 (actual)
Sponsor
Igenomix · Industry
Sex
Female
Age
18 Years – 37 Years
Healthy volunteers
Not accepted

Summary

This project seeks to demonstrate the clinical value of the personalised diagnosis of the endometrial factor in infertility.

Detailed description

This project seeks to investigate differences in implantation (IR), pregnancy (PR), ongoing pregnancy (OP) rates, miscarriages, deliveries (LB) and obstetrical, delivery and neonatal outcomes among women undergoing IVF treatment with own oocytes, at first site appointment (up to 3 previous implantation failures in other sites) and blastocyst stage (day 5 or 6). Patients are allocated through computer-generated randomization into one of the three groups: Fresh embryo transfer (ET), Frozen embryo transfer (FET) or personalized embryo transfer (pET) after identification of the personalized window of implantation using the endometrial receptivity analysis (ERA) test, all of them following the usual clinical practice in a same-cycle embryo transfer. A total of 546 infertile women under 38 years old undergoing her first IVF/ICSI cycle with elective blastocyst transfer are randomized in this prospective, multicenter, open label and controlled trial.

Conditions

Interventions

TypeNameDescription
OTHERpersonalized Embryo Transfer (pET)
OTHERFrozen Embryo Transfer (FET)
OTHERFresh Embryo Transfer (ET)

Timeline

Start date
2013-11-25
Primary completion
2018-08-31
Completion
2018-08-31
First posted
2013-10-07
Last updated
2019-02-27

Locations

16 sites across 7 countries: Belgium, Brazil, Bulgaria, Japan, Panama, Spain, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01954758. Inclusion in this directory is not an endorsement.